Mode
Text Size
Log in / Sign up
N/A N=50 Randomized Single-blind Treatment

Comparison of I-gel to the Laryngeal Mask Airway

Endotracheal Intubation · Supraglottic Airway

Enrolled (actual)
50
Serious AEs
0.0%
Results posted
Apr 2011
Primary outcome: Primary: Time Required for Intubation — 21.04; 30.04 seconds — p=0.02

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
i-gel airway (Intersurgical Ltd., Wokingham, England) (Device); Laryngeal Mask Airway-Unique (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
The University of Texas Health Science Center, Houston
Primary completion
Aug 2008

Outcome Measures

OutcomeResultp-value
PRIMARY
Time Required for Intubation
21.04; 30.04 0.02 sig
PRIMARY
Leak Pressure
23.08; 20.88 0.22
SECONDARY
Level of Difficulty for Intubation
11; 8; 12; 17; 0; 0 0.22
SECONDARY
Number of Participants With Oropharyngeal Discomfort
6; 10; 19; 15
SECONDARY
Number of Participants With Successful Gastric Drainage Tube Placement as Assessed by Fiberoptic Scope Visualization
22; 2; 1
SECONDARY
Number of Attempts
17; 21; 7; 3; 1; 1 0.03 sig

Summary

The purpose of this study is to evaluate a new disposable supra-glottic airway device, the i-gel airway (Intersurgical Ltd., Wokingham, England). We propose to test its ease of insertion, position within the airway, drain tube patency and anatomic sealing properties during mechanical ventilation in non-obese anesthetized patients undergoing elective general surgery. The study device will be compared to the current standard in the industry, the LMA Unique.

Eligibility Criteria

Inclusion Criteria

  • The subjects will be adult surgical candidates aged 18-80, ASA I-II, Mallampati I or II, presenting for elective surgery who require general anesthesia in whom tracheal intubation is not necessary.
  • Both male and female patients will be included.

Exclusion Criteria

Patients will be excluded from the study if they present as Mallampati III or IV, ASA III-V or emergency status. Additionally, they will be excluded if they meet one of the contraindication criteria of the LMA including:

  • obesity, (BMI > 35 kg/m2)
  • pregnancy
  • history of gastric regurgitation, heart burn, ileus or "full stomach"
  • history of low pulmonary compliance or high pulmonary resistance
  • known history of difficult endotracheal intubation or signs suggesting the possibility of difficult intubation
  • pharyngeal pathology
  • upper airway obstruction due to laryngeal pathology
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00706823). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search